KIRSCH ARTHUR S
SEC insider (Form 3/4/5 filer). CIK 0001290976. Director at Evommune, Inc. (EVMN) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in PALO ALTO, CA.
Companies KIRSCH ARTHUR S has filed insider reports for
- Evommune, Inc. (EVMN): Director
- Atea Pharmaceuticals, Inc. (AVIR): Director
- Liquidia Corp (LQDA): Director
KIRSCH ARTHUR S
CIK: 0001290976
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 7, 2026EVMN
Evommune, Inc.
PurchaseIndirect10K shares at avg. $13.30$133K - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
26.7K shares- - Jun 16, 2026LQDA
Liquidia Corp
AwardDirect5.9K shares- - Jun 3, 2026LQDA
Liquidia Corp
SaleIndirect10K shares at avg. $54.80$548K - Jun 2, 2026EVMN
Evommune, Inc.
AwardDirectStock Option (Right to buy)
15.7K shares- - Jun 2, 2026LQDA
Liquidia Corp
SaleIndirect5K shares at avg. $56.00$280K - Jun 1, 2026LQDA
Liquidia Corp
SaleIndirect15K shares at avg. $60.22$903K - Nov 5, 2025EVMN
Evommune, Inc.
AwardDirectStock Option (Right to Buy)
38K shares- - Jun 17, 2025LQDA
Liquidia Corp
AwardDirect18.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 |  EVMN Evommune, Inc. | Purchase | 10,000 | $13.30 | $133,000 | Indirect |
| Jun 18, 2026 |  AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 26,700 | - | - | Direct |
| Jun 16, 2026 |  LQDA Liquidia Corp | Award | 5,882 | - | $0 | Direct |
| Jun 3, 2026 | LQDA Liquidia Corp | Sale | 10,000 | $54.80 | $548,000 | Indirect |
| Jun 2, 2026 | EVMN Evommune, Inc. | Award Stock Option (Right to buy) | 15,673 | - | - | Direct |
| Jun 2, 2026 | LQDA Liquidia Corp | Sale | 5,000 | $56.00 | $280,000 | Indirect |
| Jun 1, 2026 | LQDA Liquidia Corp | Sale | 15,000 | $60.22 | $903,300 | Indirect |
| Nov 5, 2025 | EVMN Evommune, Inc. | Award Stock Option (Right to Buy) | 37,960 | - | - | Direct |
| Jun 17, 2025 | LQDA Liquidia Corp | Award | 18,396 | - | - | Direct |
1-10 of 11 transactions